Cargando…
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
The concept that blood supply is required and necessary for cancer growth and spreading is intuitive and was firstly formalized by Judah Folkman in 1971, when he demonstrated that cancer cells release molecules able to promote the proliferation of endothelial cells and the formation of new vessels....
Autores principales: | Comunanza, Valentina, Bussolino, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725406/ https://www.ncbi.nlm.nih.gov/pubmed/29270405 http://dx.doi.org/10.3389/fcell.2017.00101 |
Ejemplares similares
-
Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020) -
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
por: Montemagno, Christopher, et al.
Publicado: (2020) -
Amino Acid Transporter SLC6A14 (ATB(0,+)) – A Target in Combined Anti-cancer Therapy
por: Nałęcz, Katarzyna A.
Publicado: (2020) -
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
por: Teixeira, Adilson Fonseca, et al.
Publicado: (2020) -
Exosomes as Drug Carriers in Anti-Cancer Therapy
por: Chen, Lan, et al.
Publicado: (2022)